Evidence map›Paper›PMID 37916071›Full record

ArticleHeliyon2023

Magnetic layered double hydroxides with carbamazepine for breast cancer treatment.

M Florencia Peralta, Silvia N Mendieta, I Romina Scolari, M Verónica Gerbaldo, Marcos I Oliva, Germán A Gil, Gladys E Granero, Mónica E Crivello

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

M Florencia PeraltaCentro de Investigación y Tecnología Química (CITeQ), UTN-CONICET, Av. Cruz Roja Argentina y Maestro López, Córdoba, 5000, Argentina.
Silvia N MendietaCentro de Investigación y Tecnología Química (CITeQ), UTN-CONICET, Av. Cruz Roja Argentina y Maestro López, Córdoba, 5000, Argentina.
I Romina ScolariUnidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), UNC-CONICET, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Av. Medina Allende S/N, Córdoba, 5000, Argentina.
M Verónica GerbaldoCentro de Investigación y Tecnología Química (CITeQ), UTN-CONICET, Av. Cruz Roja Argentina y Maestro López, Córdoba, 5000, Argentina.
Marcos I OlivaInstituto de Física Enrique Gaviola (IFEG), UNC-CONICET, Facultad de Matemática, Astronomía, Física y Computación, UNC, Av. Medina Allende S/N, Córdoba, 5000, Argentina.
Germán A GilCentro de Investigaciones en Química Biológica de Córdoba (CIQUIBIC), UNC-CONICET, Av. Haya de la Torre S/N, Córdoba, 5000, Argentina.
Gladys E GraneroUnidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), UNC-CONICET, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Av. Medina Allende S/N, Córdoba, 5000, Argentina.
Mónica E CrivelloCentro de Investigación y Tecnología Química (CITeQ), UTN-CONICET, Av. Cruz Roja Argentina y Maestro López, Córdoba, 5000, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current cancer chemotherapy is associated with many side effects and, in some cases, drug resistance, which makes the search for new active molecules and drug delivery strategies imperative. Carbamazepine is an antiepileptic compound that has shown efficacy against breast cancer cell lines. In this study, it was incorporated into layered double hydroxide nanoclays, the percentage of drug loading was increased compared to previous research, and the clays were impregnated with magnetic Fe

Indexed as

Cancer therapyCarbamazepineLayered double hydroxideNanoclayNanoparticle

Identifiers

PMID37916071
PMCPMC10616332
OpenAlexW4387642889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.